MedPath

Fast-track Surgery in the Treatment of Hirschsprung's Disease

Not Applicable
Conditions
Surgery
Interventions
Drug: probiotics
Drug: placebo
Registration Number
NCT02350088
Lead Sponsor
Tongji Hospital
Brief Summary

To evaluate the safety and efficacy of Hirschsprung's disease

Detailed Description

The patients are divided into two groups:fast-track surgery combined with laparoscope group and laparoscope with traditional managements group.Postoperative recovery,hospital stay,hospital cost and complcations were compared.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. surgical treatment for Hirschsprung's disease
  2. The first procedure for Hirschsprung's disease
  3. Age<14 years
Exclusion Criteria
  1. conservative treatment for Hirschsprung's disease
  2. The reoperation for Hirschsprung's disease
  3. Age>14 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fast-track Surgeryprobioticsprobiotics,oral,b.i.d.
Traditional Groupplaceboplacebo,oral,b.i.d.
Primary Outcome Measures
NameTimeMethod
number of participants with recovery of boewl movementsone year
Secondary Outcome Measures
NameTimeMethod
Duration of the hospital stayone year

Trial Locations

Locations (1)

Tongji Hospital

🇨🇳

Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath